International Regulatory Pathways Have Supported Drug Development Across Biotech and Pharma
Go back to International Regulatory Pathways Have Supported Drug Development Across Biotech and Pharma| (NASDAQ: BBIO) | Delayed: 74.48 +2.47 (3.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $72.01 | 52 Week High | $ | |||
| Open | $72.53 | 52 Week Low | $ | |||
| Day High | $74.65 | P/E | N/A | |||
| Day Low | $71.78 | EPS | $ | |||
| Volume | 3,393,289 | |||||
| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 216.06 -0.57 (0.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $216.63 | 52 Week High | $333.65 | |||
| Open | $218.00 | 52 Week Low | $223.02 | |||
| Day High | $218.00 | P/E | 27.66 | |||
| Day Low | $212.58 | EPS | $7.81 | |||
| Volume | 1,091,323 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1199.43 -30.5 (2.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1229.93 | 52 Week High | $88.16 | |||
| Open | $1228.88 | 52 Week Low | $67.88 | |||
| Day High | $1230.05 | P/E | 277.65 | |||
| Day Low | $1190.20 | EPS | $4.32 | |||
| Volume | 3,722,656 | |||||
| (NASDAQ: NTHI) | Delayed: 4.53 +0.10 (2.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.43 | 52 Week High | $ | |||
| Open | $4.43 | 52 Week Low | $ | |||
| Day High | $4.56 | P/E | N/A | |||
| Day Low | $4.38 | EPS | $ | |||
| Volume | 60,325 | |||||

